Dr. Brat is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
303 E Chicago Ave
# 3140W127
Chicago, IL 60611Phone+1 312-503-8144
Education & Training
Johns Hopkins UniversityFellowship, Neuropathology, 1997 - 1999- Johns Hopkins UniversityResidency, Pathology-Anatomic and Clinical, 1994 - 1997
Mayo Clinic College of MedicineClass of 1994
Certifications & Licensure
IL State Medical License 2017 - 2026
GA State Medical License 1999 - 2019
MD State Medical License 1997 - 2000
American Board of Pathology Anatomic Pathology- American Board of Pathology Neuropathology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
Publications & Presentations
PubMed
- A clinically relevant model and method to study necrosis as a driving force in glioma restructuring and progression.Jiabo Li, Ling-Kai Shih, Steven M Markwell, Cheryl L Olson, David P Sullivan
Proceedings of the National Academy of Sciences of the United States of America. 2025-02-18 - 5 citationscIMPACT-NOW update 8: Clarifications on molecular risk parameters and recommendations for WHO grading of meningiomas.Felix Sahm, Kenneth D Aldape, Priscilla K Brastianos, Daniel J Brat, Sonika Dahiya
Neuro-Oncology. 2025-02-10 - Accurate identification of primary site in tumors of unknown origin (TUO) using DNA methylation.Drew Duckett, Erica R Vormittag-Nocito, Pouya Jamshidi, Madina Sukhanova, Stephanie Parker
NPJ Precision Oncology. 2025-01-10
Press Mentions
New CAP Guideline Improves Testing, Care, for Patients with Diffuse GliomasFebruary 17th, 2022- Northwestern Selected as Home for Journal of Clinical Investigation; McNally to Serve as Editor-in-ChiefDecember 14th, 2021
CAP Opens Comment Period on Diffuse Glioma Guideline; Participate to Improve Patient OutcomesSeptember 9th, 2019- Join now to see all
Grant Support
- Targeted Delivery Of A Novel Synthetic Curcumin Analog, EF24 To Glioblastoma AndNational Cancer Institute2011–2012
- Regulation Of Asymmetric Cellular Division In Glioma Stem CellsNational Cancer Institute2011–2012
- Tissue CoreNational Cancer Institute2009–2011
- Animal Models And PathologyNational Cancer Institute2008–2011
- Vaso-Occlusive Mechanisms That Induce Hypoxia And Cause Glioma Progression.National Institute Of Neurological Disorders And Stroke2006–2010
- Core D: Animal Models And PathologyNational Cancer Institute2007
- Comparative DNA Microarray Analysis Of Brain TumorsNational Institute Of Neurological Disorders And Stroke2002–2006
- Intravascular Thrombosis In GlioblastomaNational Cancer Institute2005
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
